cached image

Colin L. Masters, B MED SCI (HONS), MBBS, MD, FRCPath, FRCPA, FAA

Affiliations: 
Mental Health Research Institute University of Melbourne, Parkville, Victoria, Australia 
Area:
Alzheimer's disease, amyloid
Website:
http://www.mhri.edu.au/board.htm#director
Google:
"Colin Masters"
Bio:

Executive Director and Laureate Professor
Appointed Institute Director in 2007.
Former Director of Prana Biotechnology and Laureate Professor at Melbourne University's School of Medicine

http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=12

Mean distance: 18.34 (cluster 28)
 
Cross-listing: Alzheimer's Tree - Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McDade E, Voytyuk I, Aisen P, et al. (2021) The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nature Reviews. Neurology
Mukherjee S, Perez KA, Dubois C, et al. (2021) Citrullination of Amyloid-β Peptides in Alzheimer's Disease. Acs Chemical Neuroscience
Chatterjee P, Pedrini S, Ashton NJ, et al. (2021) Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Hampel H, Hardy J, Blennow K, et al. (2021) The Amyloid-β Pathway in Alzheimer's Disease. Molecular Psychiatry
Huq AJ, Fulton-Howard B, Riaz M, et al. (2021) Polygenic score modifies risk for Alzheimer's disease in ε4 homozygotes at phenotypic extremes. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12226
Stehmann C, Senesi M, Sarros S, et al. (2021) Erratum to: Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020. Communicable Diseases Intelligence (2018). 45
Fowler C, Rainey-Smith SR, Bird S, et al. (2021) Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 5: 443-468
Chen CD, Joseph-Mathurin N, Sinha N, et al. (2021) Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathologica
Stehmann C, Senesi M, Sarros S, et al. (2021) Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2020. Communicable Diseases Intelligence (2018). 45
Fagan AM, Henson RL, Li Y, et al. (2021) Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 20: 615-626
See more...